Autonomix Medical Statistics
Total Valuation
AMIX has a market cap or net worth of $4.69 million. The enterprise value is $1.23 million.
| Market Cap | 4.69M |
| Enterprise Value | 1.23M |
Important Dates
The last earnings date was Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AMIX has 971,043 shares outstanding. The number of shares has increased by 316.60% in one year.
| Current Share Class | 971,043 |
| Shares Outstanding | 971,043 |
| Shares Change (YoY) | +316.60% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 1.74% |
| Owned by Institutions (%) | 5.81% |
| Float | 954,178 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.83 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.85
| Current Ratio | 4.85 |
| Quick Ratio | 4.23 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -315.99% and return on invested capital (ROIC) is -200.89%.
| Return on Equity (ROE) | -315.99% |
| Return on Assets (ROA) | -157.81% |
| Return on Invested Capital (ROIC) | -200.89% |
| Return on Capital Employed (ROCE) | -518.12% |
| Weighted Average Cost of Capital (WACC) | -2.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.46M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.46% in the last 52 weeks. The beta is -1.15, so AMIX's price volatility has been lower than the market average.
| Beta (5Y) | -1.15 |
| 52-Week Price Change | -79.46% |
| 50-Day Moving Average | 6.31 |
| 200-Day Moving Average | 9.37 |
| Relative Strength Index (RSI) | 43.63 |
| Average Volume (20 Days) | 8,489,421 |
Short Selling Information
The latest short interest is 108,801, so 11.20% of the outstanding shares have been sold short.
| Short Interest | 108,801 |
| Short Previous Month | 263,441 |
| Short % of Shares Out | 11.20% |
| Short % of Float | 11.40% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.38M |
| Pretax Income | -16.11M |
| Net Income | -16.11M |
| EBITDA | -16.37M |
| EBIT | -16.38M |
| Earnings Per Share (EPS) | -$36.37 |
Balance Sheet
The company has $3.46 million in cash and no debt, with a net cash position of $3.46 million or $3.56 per share.
| Cash & Cash Equivalents | 3.46M |
| Total Debt | n/a |
| Net Cash | 3.46M |
| Net Cash Per Share | $3.56 |
| Equity (Book Value) | 3.16M |
| Book Value Per Share | 5.83 |
| Working Capital | 3.15M |
Cash Flow
In the last 12 months, operating cash flow was -$13.22 million and capital expenditures -$10,000, giving a free cash flow of -$13.23 million.
| Operating Cash Flow | -13.22M |
| Capital Expenditures | -10,000 |
| Depreciation & Amortization | 12,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -13.23M |
| FCF Per Share | -$13.63 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AMIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -316.60% |
| Shareholder Yield | -316.60% |
| Earnings Yield | -343.40% |
| FCF Yield | -282.12% |
Analyst Forecast
The average price target for AMIX is $58.80, which is 1,117.39% higher than the current price. The consensus rating is "Buy".
| Price Target | $58.80 |
| Price Target Difference | 1,117.39% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 24, 2026. It was a reverse split with a ratio of 1:21.
| Last Split Date | Jun 24, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:21 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |